DAFFNEY PERKINS: Open Payments
NPI 1891432571 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 31 payments from 9 companies in 2025. Trend: 2023 $75 · 2024 $239 · 2025 $671
Food & beverage: $671
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $164 |
| Novartis Pharmaceuticals Corporation | 11 | $141 |
| ABIOMED | 1 | $128 |
| Alnylam Pharmaceuticals Inc. | 8 | $126 |
| BridgeBio Pharma, Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| CVRx, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| PFIZER INC. | 1 | $16 |
Products named: JARDIANCE, LEQVIO, AMVUTTRA, Attruby, EVKEEZA, Barostim Neo System, CAMZYOS, VYNDAQEL.
Industry payments across AR — which companies pay providers there.
